Incorporate robust, flexible CAR-T Cell Enrichment and Detection into Your Manufacturing and QC Workflows
CST revolutionized pre-clinical CAR cell characterization with universal recombinant monoclonal antibodies specific to the ubiquitous Whitlow/218 and G4S linker sequences of scFv-based CARs. This innovation enabled scientists to use a single reagent for a variety of assays without the time or cost of developing anti-idiotype antibodies for every CAR construct.
These trusted antibody conjugates, manufactured to be GMP-grade, are intended to simplify enrichment of G4S linker CAR+ cells and increase productivity for in-process QC and lot release assays. When pre-clinical development teams use the same reagents, handoffs to clinical production can be that much easier.
Inquire for Availability
|
CAR+ Cell Enrichment in Manufacturing |
|
G4S Linker (E7O2V) Rabbit Monoclonal Antibody (Biotin Conjugate) (GMP-Grade)
- Enrich any G4S linker-containing CAR-T cell with one reagent
- Biotin-conjugated antibodies are amenable to magnetic bead-based CAR-T cell enrichment on cell therapy manufacturing instrumentation
- Standardize percent CAR-positive cells and mitigate issues associated with low transduction efficiencies
- Designed and manufactured to GMP-grade reagent standards (Full GMP certification and commercial quantities available mid-2026)
|
Inquire for Availability
|
CAR+ Cell Detection for Analytical QC |
|
G4S Linker (E7O2V) Rabbit Monoclonal Antibody (PE Conjugate) (GMP-Grade)
- Detect any G4S linker-containing CAR-T cell with one reagent
- Simplify in-process QC and lot release assays
- PE-conjugated antibodies plug into your existing analytical QC workflows
- Amenable to CAR+ cell detection in flow cytometry and FACS-based enrichment
- Designed and manufactured to GMP-grade reagent standards (Full GMP Certification & Commercial Quantities available mid-2026)
|
Inquire for Availability
|
Seamless Transfer from Pre-Clinical to Clinical |
- Smoother handoffs when the same GMP-grade reagents are used in pre-clinical development as in manufacturing and QC
- Save time when you don't have to qualify reagents for clinical environments
|
|
Reagent Security and Supply Continuity |
- Compliant GMP process and required documentation as well as controlled chain-of-custody ensure traceability
- Recombinant monoclonal antibodies produced from a Master Cell Bank enable lot-to-lot consistency
|
For Research and Evaluation Use Only. Commercial GMP-Grade Reagent Availability is Anticipated in Mid-2026.